Page 34 - MI-2-3
P. 34

Microbes & Immunity                                                    Correlation between VZV and cancer



            14.  Newman AM, Jhaveri R. Myths and misconceptions:   health data. Br J Dermatol. 2021;184(6):1077-1084.
               Varicella-zoster  virus  exposure,  infection  risks,     doi: 10.1111/bjd.19687
               complications, and treatments.  Clin Ther. 2019;41(9):
               1816-1822.                                      25.  Dhillon RS, Smith PD. Diskogenic reactivation of herpes
                                                                  zoster. World Neurosurg. 2018;109:138-139.
               doi: 10.1016/j.clinthera.2019.06.009
                                                                  doi: 10.1016/j.wneu.2017.09.132
            15.  Zhang Z, Liu N, Zhang J,  et al. Epidemiological
               characteristics of varicella under different immunisation   26.  Patil  A, Goldust M, Wollina  U. Herpes  zoster: A  review
               strategies in Suzhou prefecture, Jiangsu province. Vaccines   of clinical manifestations and management.  Viruses.
               (Basel). 2022;10(10):1745.                         2022;14(2):192.
               doi: 10.3390/vaccines10101745                      doi: 10.3390/v14020192
            16.  Rice  PS.  Ultra-violet  radiation  is  responsible  for  the   27.  Purohit SK, Corbett AJ, Slobedman B, Abendroth A.
               differences in global epidemiology of chickenpox and the   Varicella Zoster Virus infects mucosal associated invariant
               evolution of varicella-zoster virus as man migrated out of   T cells. Front Immunol. 2023;14:1121714.
               Africa. Virol J. 2011;8:189.
                                                                  doi: 10.3389/fimmu.2023.1121714
               doi: 10.1186/1743-422X-8-189
                                                               28.  Sen N, Mukherjee G, Arvin AM. The use of single cell mass
            17.  Institute of Medicine (U.S.). Committee to review adverse   cytometry to define the molecular mechanisms of varicella-
               effects of vaccines. In: Stratton KR, editor. Adverse Effects   zoster virus lymphotropism. Front Microbiol. 2020;11:1224.
               of Vaccines: Evidence and Causality. United States: National
               Academies Press; 2012. p. 865.                     doi: 10.3389/fmicb.2020.01224
            18.  Marin M, Lopez AS, Melgar M, Dooling K, Curns AT, Leung J.   29.  Arnold N, Messaoudi I. Simian varicella virus causes
               Decline in severe varicella disease during the United States   robust transcriptional changes in T cells that support viral
               varicella vaccination program: Hospitalizations and deaths,   replication. Virus Res. 2017;238:226-235.
               1990-2019. J Infect Dis. 2022;226(Suppl 4):S407-S415.     doi: 10.1016/j.virusres.2017.07.004
               doi: 10.1093/infdis/jiac242                     30.  Ouwendijk WJD, van Veen S, Mahalingam R, Verjans G.
            19.  Zhou F, Leung J, Marin M, Dooling KL, Anderson TC,   Simian varicella virus inhibits the interferon gamma
               Ortega-Sanchez IR. Health and economic impact of the   signalling pathway. J Gen Virol. 2017;98(10):2582-2588.
               United  States  varicella  vaccination  program,  1996-2020.      doi: 10.1099/jgv.0.000925
               J Infect Dis. 2022;226(Suppl 4):S463-S469.
                                                               31.  Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular
               doi: 10.1093/infdis/jiac271                        mechanisms of varicella zoster virus pathogenesis. Nat Rev
            20.  Depledge DP, Sadaoka T, Ouwendijk WJD. Molecular aspects   Microbiol. 014;12(3):197-210.
               of varicella-zoster virus latency. Viruses. 2018;10(7):349.     doi: 10.1038/nrmicro3215
               doi: 10.3390/v10070349                          32.  Sorel O, Messaoudi I. Varicella virus-host interactions
            21.  Doan HQ, Ung B, Ramirez-Fort MK, Khan F, Tyring SK.   during latency and reactivation: Lessons from simian
               Zostavax: A  subcutaneous vaccine for the prevention   varicella virus. Front Microbiol. 2018;9:3170.
               of herpes zoster.  Expert Opin Biol Ther. 2013;13(10):      doi: 10.3389/fmicb.2018.03170
               1467-1477.
                                                               33.  Lizzi J, Hill T, Jakubowski J. Varicella zoster virus encephalitis.
               doi: 10.1517/14712598.2013.830101                  Clin Pract Cases Emerg Med. 2019;3(4):380-382.
            22.  Serpell M, Gater A, Carroll S, Abetz-Webb L, Mannan A,      doi: 10.5811/cpcem.2019.8.43010
               Johnson R. Burden of post-herpetic neuralgia in a sample
               of UK residents aged 50 years or older: Findings from the   34.  Cross C, English S, Krause M, Zalewski N. A 59-year-old
               Zoster Quality of Life (ZQOL) study.  Health Qual Life   immunocompetent man with rapid onset of truncal ataxia:
               Outcomes. 2014;12:92.                              A case of acute cerebellitis secondary to varicella zoster
                                                                  virus. (P4.9-035). Neurology. 2019;92(15 Suppl):P4.9-035.
               doi: 10.1186/1477-7525-12-92
                                                                  doi: 10.1212/WNL.92.15_supplement.P4.9-035
            23.  Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and
               postherpetic neuralgia: Prevention and management.  Am   35.  Shoji H, Matsuo K, Matsushita T,  et al. Herpes zoster
               Fam Physician. 2017;96(10):656-663.                peripheral  nerve  complications:  Their  pathophysiology  in
                                                                  spinal ganglia and nerve roots.  Intractable Rare Dis Res.
            24.  Forbes HJ, Bhaskaran K, Grint D, et al. Incidence of acute
               complications of herpes zoster among immunocompetent   2023;12(4):246-250.
               adults in England: A matched cohort study using routine      doi: 10.5582/irdr.2023.01090


            Volume 2 Issue 3 (2025)                         26                               doi: 10.36922/mi.8320
   29   30   31   32   33   34   35   36   37   38   39